Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 334 | 9q22.33 | CTSV | cathepsin V | |
Rat | - | 334 | 17p14 | Ctsl | cathepsin L |
Previous and Unofficial Names |
cathepsin L | cathepsin L1 | CATHL | CatL | CP-2 | cyclic protein 2 | cathepsin L2 | CTSL2 | CTSU | Ctsl1 |
Database Links | |
Specialist databases | |
MEROPS | C01.009 (Hs) |
Other databases | |
Alphafold | O60911 (Hs), P07154 (Rn) |
BRENDA | 3.4.22.43 |
ChEMBL Target | CHEMBL3272 (Hs), CHEMBL2305 (Rn) |
Ensembl Gene | ENSG00000136943 (Hs), ENSRNOG00000018566 (Rn) |
Entrez Gene | 1515 (Hs), 25697 (Rn) |
Human Protein Atlas | ENSG00000136943 (Hs) |
KEGG Enzyme | 3.4.22.43 |
KEGG Gene | hsa:1515 (Hs), rno:25697 (Rn) |
OMIM | 603308 (Hs) |
Pharos | O60911 (Hs) |
RefSeq Nucleotide | NM_001201575 (Hs), NM_001333 (Hs), NM_013156 (Rn) |
RefSeq Protein | NP_001324 (Hs), NP_001188504 (Hs), NP_037288 (Rn) |
UniProtKB | O60911 (Hs), P07154 (Rn) |
Wikipedia | CTSV (Hs) |
Selected 3D Structures | |||||||||||||
|
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
1. Elie BT, Gocheva V, Shree T, Dalrymple SA, Holsinger LJ, Joyce JA. (2010) Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie, 92 (11): 1618-24. [PMID:20447439]
2. Severino RP, Guido RV, Marques EF, Brömme D, da Silva MF, Fernandes JB, Andricopulo AD, Vieira PC. (2011) Acridone alkaloids as potent inhibitors of cathepsin V. Bioorg Med Chem, 19 (4): 1477-81. [PMID:21277783]
3. Somoza JR, Zhan H, Bowman KK, Yu L, Mortara KD, Palmer JT, Clark JM, McGrath ME. (2000) Crystal structure of human cathepsin V. Biochemistry, 39 (41): 12543-51. [PMID:11027133]
4. Tato M, Kumar SV, Liu Y, Mulay SR, Moll S, Popper B, Eberhard JN, Thomasova D, Rufer AC, Gruner S et al.. (2017) Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury. Sci Rep, 7 (1): 2775. [PMID:28584258]
C1: Papain: cathepsin V. Last modified on 20/04/2021. Accessed on 16/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2352.